Have we turned a Covid-19 corner?
In England, where about one person in 50 have Covid, case numbers are falling

“Whisper it,” said Kat Lay and Tom Whipple in The Times, “but there are – perhaps – signs that it could be safe to press ahead with planning for Christmas.” Surveys suggest that coronavirus in the UK may be in retreat.
In England, where about one person in 50 have Covid, case numbers are falling, largely as a result of a drop of infections among secondary-school children. Scientists have cautioned that this downward trend may just be a temporary effect of half-term.
They’ve also warned that cases are still rising among the over-50s as a result of waning immunity. But with booster jabs dealing with that latter problem, and the prospect of new antiviral treatments on the way, the “mood music is beginning to sound optimistic”.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
The antiviral pills could be “game changers”, said Matthew Lesh in The Daily Telegraph. Merck’s drug, molnupiravir, which was licensed last week for use in the UK, reduced hospitalisation by 50% among vulnerable people in trials. Pfizer, meanwhile, announced last week that its new antiviral pill, Paxlovid, which is set to be licensed in the UK early next year, reduces hospitalisation by 89%. With these drugs, and others like them, Covid could become a “treatable, uninteresting, even run-of-the-mill, virus”. The only problem is that the UK has so far secured a very limited supply of these pills.
We can’t afford to drop our guard against Covid yet, said The Guardian. As England’s deputy chief medical officer, Prof Jonathan Van-Tam, warned last week, the pandemic is far from over. Indeed, it’s now raging through Europe again.
The recent decision by Jeremy Farrar to walk out of Sage, the Government’s Scientific Advisory Group for Emergencies, showed that some experts feel strongly that the Government is no longer “following the science”, said Mary Dejevsky in The Independent. They may be right; but many of their previous warnings have proved too alarmist, and their opinions should be just one of many that are taken into account.
Ultimately, it must be left to politicians to decide whether or not to reimpose restrictions. “The pandemic may not be quite on its last legs, but it is a positive development that UK ministers and scientists are returning to their separate tracks.”
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
-
A running list of RFK Jr.'s controversies
In Depth The man atop the Department of Health and Human Services has had no shortage of scandals over the years
By Brigid Kennedy
-
Film reviews: Sinners and The King of Kings
Feature Vampires lay siege to a Mississippi juke joint and an animated retelling of Jesus' life
By The Week US
-
Music reviews: Bon Iver, Valerie June, and The Waterboys
Feature "Sable, Fable," "Owls, Omens, and Oracles," "Life, Death, and Dennis Hopper"
By The Week US
-
Mental health: a case of overdiagnosis?
Talking Point Issues at 'the milder end of the spectrum' may be getting wrongly pathologised
By The Week UK
-
Fighting against fluoride
Feature A growing number of communities are ending water fluoridation. Will public health suffer?
By The Week US
-
Five years on: How Covid changed everything
Feature We seem to have collectively forgotten Covid’s horrors, but they have completely reshaped politics
By The Week US
-
Bird flu: The viral threat pushing up egg prices
Feature
By The Week US
-
Why is the FDA slow to ban food additives?
Today's big question A legal loophole lets things slide
By Devika Rao, The Week US
-
HMPV is spreading in China but there's no need to worry
The Explainer Respiratory illness is common in winter
By Devika Rao, The Week US
-
Marty Makary: the medical contrarian who will lead the FDA
In the Spotlight What Johns Hopkins surgeon and commentator Marty Makary will bring to the FDA
By David Faris
-
Will the murder of a health insurance CEO cause an industry reckoning?
Today's Big Question UnitedHealthcare CEO Brian Thompson was shot and killed in what police believe was a targeted attack
By Justin Klawans, The Week US